Citation Impact
Citing Papers
Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma
2019
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Characterization and analyses of multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphisms in Chinese population
2009
A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies
2016 Standout
Lineage-Specific Changes in Biomarkers in Great Apes and Humans
2015 StandoutNobel
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II
2010
The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis
2017
Traditional Chinese Medicine for Cardiovascular Disease
2017 Standout
Doxorubicin pathways
2010 Standout
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Oral Anticoagulant Therapy
2012 Standout
Cardiovascular actions and therapeutic potential of tanshinone IIA
2011
Antiplatelet Effects of MK‐852, a Platelet Fibrinogen Receptor Antagonist, in Healthy Volunteers
2000
Ticlopidine
1990
Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data
2012
CYP2C9 Genotype-guided Warfarin Prescribing Enhances the Efficacy and Safety of Anticoagulation: A Prospective Randomized Controlled Study
2007
Genome-wide association meta-analysis for total serum bilirubin levels
2009
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I
2010
Gastric cancer
2020 Standout
Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective
2013
Enhanced onset of platelet inhibition with a loading dose of ticlopidine in ASA-treated stable coronary patients
1998 StandoutNobel
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Liver expression quantitative trait loci: a foundation for pharmacogenomic research
2012
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition
2011
Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review
2020 Standout
Historical Perspective of Traditional Indigenous Medical Practices: The Current Renaissance and Conservation of Herbal Resources
2014 Standout
Cytochrome P450 enzyme mediated herbal drug interactions (Part 1)
2014
Nutritional Supplementation Increases Rifampin Exposure among Tuberculosis Patients Coinfected with HIV
2014
Serum Bilirubin and Genes Controlling Bilirubin Concentrations as Biomarkers for Cardiovascular Disease
2010
Effects of Tuberculosis, Race, and Human Gene SLCO1B1 Polymorphisms on Rifampin Concentrations
2010
Toxicological Effects of Glycyrrhiza glabra (Licorice): A Review
2017
Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review
2018 Standout
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Pharmacogenomics of Oral Antidiabetic Medications: Current Data and Pharmacoepigenomic Perspective
2011
Transient elastography compared to serum markers to predict liver fibrosis in a cohort of C hinese patients with chronic hepatitis B
2014
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Pharmacokinetic Interactions of Herbs with Cytochrome P450 and P-Glycoprotein
2015
Personalized Therapy in Pain Management: Where Do We Stand?
2010
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of Yijing He being referenced
Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males
2006
Effect of bifendate on the pharmacokinetics of cyclosporine in relation to the CYP3A4*18B genotype in healthy subjects
2009
Effect of the CYP2C9*3 allele on lornoxicam metabolism
2005
Discordance of Somatic Mutations Between Asian and Caucasian Patient Populations with Gastric Cancer
2016
INHIBITION OF ADP‐INDUCED PLATELET AGGREGATION BY CLOPIDOGREL IS RELATED TOCYP2C19GENETIC POLYMORPHISMS
2008
Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide
2006
Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism
2009
SLCO1B1 521T→C functional genetic polymorphism and lipid‐lowering efficacy of multiple‐dose pravastatin in Chinese coronary heart disease patients
2007
Effect of bifendate on the pharmacokinetics of talinolol in healthy subjects
2009
OATP1B1 POLYMORPHISM IS A MAJOR DETERMINANT OF SERUM BILIRUBIN LEVEL BUT NOT ASSOCIATED WITH RIFAMPICIN‐MEDIATED BILIRUBIN ELEVATION
2007
Copy number variants in pharmacogenetic genes
2011
Ticlopidine in China: Comparative Study on the Effect of Two Dose Levels on Bleeding Time and Platelet Function in Healthy Volunteers
1989
Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers
2009
Effect of glycyrrhizin on the activity of CYP3A enzyme in humans
2010
Organic anion transporting polypeptide-1B1 haplotypes in Chinese patients
2007
Copy number variants in pharmacogenetic genes
2020
Lack of Effect of Ginkgo biloba on Voriconazole Pharmacokinetics in Chinese Volunteers Identified as CYP2C19 Poor and Extensive Metabolizers
2009
Effects of Ginkgo biloba Extract Ingestion on the Pharmacokinetics of Talinolol in Healthy Chinese Volunteers
2009